指南与共识技术与安全泌尿生殖介入CTMRDSA

肾功能受损患者血管内对比剂的使用——波兰肾脏病学会与波兰医学放射学会联合临床实践立场声明

The use of intravascular contrast media in patients with impaired kidney function - joint clinical practice position statement of the Polish Society of Nephrology and the Polish Medical Society of Radiology.
指南 / 共识 · Pol J Radiol · 2024-03-21

该联合立场声明由肾脏病学家与放射科医生跨学科团队制定,针对肾功能受损患者使用血管内对比剂(ICM)提出更新指南。声明指出,人类中未证实对比剂给药与血清肌酐升高之间存在直接因果关系,当代研究模型和荟萃分析未将急性肾损伤与对比剂使用相关联,因此强调目前所理解的肾毒性风险较低,并放宽了既往对肾功能不全患者的限制性做法。

要点

  • 对比剂给药与血清肌酐升高之间未证实直接因果关系,当代研究与荟萃分析未将急性肾损伤与对比剂使用关联。
  • 声明强调目前所理解的对比剂肾毒性风险较低,放宽了既往对肾功能不全患者的限制性做法。
  • 既往限制性指南基于历史证据,可能阻碍急性肾损伤和慢性肾脏病患者接受关键放射学干预。

核心结论

  • 更新指南强调肾功能受损患者使用血管内对比剂的肾毒性风险较既往认识降低,并放宽了既往限制性做法。

研究设计与样本

  • 由肾脏病学家与放射科医生跨学科团队制定的联合临床实践立场声明,制定机构为波兰肾脏病学会与波兰医学放射学会;原文未报告系统检索方法、证据分级及样本量。

诊断标准与关键数值

  • 人类中未证实对比剂给药与血清肌酐升高之间存在直接因果关系。
  • 当代研究模型和荟萃分析未将急性肾损伤与对比剂使用相关联。
  • 既往指南因 perceived 肾毒性风险限制肾功能受损患者使用血管内对比剂,声明对此予以放宽。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radiological procedures utilising intravascular contrast media (ICM) are fundamental to modern medicine, enhancing diagnostics and treatment in diverse medical fields. However, the application of ICM has been constrained in patients with compromised kidney function due to perceived nephrotoxic risks, called contrast-induced nephropathy or contrastinduced acute kidney injury. Historical evidence marked ICM as a possible contributor to kidney damage. This led to restrictive guidelines advocating limited ICM use in patients with impaired renal function, preventing crucial radiographic interventions in patients with acute kidney injury (AKI) and chronic kidney disease. Recent advances challenge these traditional views. In particular, no direct causal relationship has been confirmed between contrast admi-nistration and elevated serum creatinine concentrations in humans. Furthermore, contemporary research models and meta-analyses do not associate AKI with contrast usage. This paper, prepared by a cross-disciplinary team of nephrologists and radiologists, presents updated guidelines for ICM application amid renal function impairments, emphasising the reduced nephrotoxic risks currently understood and loosening the previous restrictive approach in patients with renal dysfunction.

来源:Pol J Radiol,查看原文。版权归原作者所有。

引用

  1. Chmielewski M, Serafin Z, Kamińska D, et al. The use of intravascular contrast media in patients with impaired kidney function - joint clinical practice position statement of the Polish Society of Nephrology and the Polish Medical Society of Radiology. Pol J Radiol. 2024. PMID: 38550960. doi:10.5114/pjr.2024.136950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。